arrow
Back
C

C. Logothetis

utmd anderson cancer center

25H-index
134Paper Count
4.7KCitation Count
Published Papers 20
Publication Date
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
err2024-11-09
err0
errOAAI
errGregg, Justin R.; Newcomb, Lisa; Wu, Ranran; Dennison, Jennifer; Davis, John W.; Pettaway, Curtis; Pisters, Louis; Ward, John F.; Chapin, Brian F.; Chery, Lisly; Urkmez, Ahmet; Fang, Andrew M.; Higgason, Noel; Troncoso, Patricia; Daniel, Carrie R.; Logothetis, Christopher; Thompson, Timothy C.; Hahn, Andrew W.; Liu, Menghan; Zheng, Yingye; Lin, Dan W.; Hanash, Samir; Irajizad, Ehsan; Fahrmann, Johannes
errShare
errSave
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration -resistant prostate cancer y
err2020-07-01
err13
errOAAI
errHalabi, S.; Dutta, S.; Tangen, C. M.; Rosenthal, M.; Petrylak, D. P.; Thompson, I. M., Jr.; Chi, K. N.; De Bono, J. S.; Araujo, J. C.; Logothetis, C.; Eisenberger, M. A.; Quinn, D. I.; Fizazi, K.; Morris, M. J.; Higano, C. S.; Tannock, I. F.; Small, E. J.; Kelly, W. K.
errShare
errSave
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 (vol 26, pg 1589, 2015)
err2019-12-01
err11
errOAAI
errGillessen, S.; Omlin, A.; Attard, G.; De Bono, J. S.; Efstathiou, E.; Fizazi, K.; Halabi, S.; Nelson, P. S.; Sartor, O.; Smith, M. R.; Soule, H. R.; Akaza, H.; Beer, T. M.; Beltran, H.; Chinnaiyan, A. M.; Daugaard, G.; Davis, I. D.; De Santis, M.; Drake, C. G.; Eeles, R. A.; Fanti, S.; Gleave, M. E.; Heidenreich, A.; Hussain, M.; James, N. D.; Lecouvet, F. E.; Logothetis, C. J.; Mastris, K.; Nilsson, S.; Oh, W. K.; Olmos, D.; Padhani, A. R.; Parker, C.; Rubin, M. A.; Schalken, J. A.; Scher, H. I.; Sella, A.; Shore, N. D.; Small, E. J.; Sternberg, C. N.; Suzuki, H.; Sweeney, C. J.; Tannock, I. F.; Tombal, B.
errShare
errSave
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
err2017-12-01
err18
PREAI
errLoriot, Y.; Pagliaro, L.; Flechon, A.; Mardiak, J.; Geoffrois, L.; Kerbrat, P.; Chevreau, C.; Delva, R.; Rolland, F.; Theodore, C.; Roubaud, G.; Gravis, G.; Eymard, J. C.; Malhaire, J. P.; Linassier, C.; Habibian, M.; Martin, A. L.; Journeau, F.; Reckova, M.; Logothetis, C.; Laplanche, A.; Le Teuff, G.; Culine, S.; Fizazi, K.
errShare
errSave
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer
err2017-08-01
err4
errOAAI
errPezaro, C. J.; Omlin, A.; Mastris, K.; Attard, G.; Beer, T. M.; Chi, K. N.; Chowdhury, S.; Davis, I. D.; Drake, C. G.; de Bono, J. S.; Efstathiou, E.; Gravis, G.; Higano, C. S.; Hussain, M.; James, N.; Logothetis, C. J.; Morgans, A.; Parker, C.; Ryan, C. J.; Saad, F.; Sartor, O.; Small, E. J.; Sternberg, C. N.; Sweeney, C. J.; Tannock, I.; Tombal, B.; Gillessen, S.
errShare
errSave
Abiraterone acetate (AA) followed by randomization to dasatinib (D) or sunitinib malate (S) in metastatic castrate resistant prostate cancer (mCRPC)
err2016-10-01
err0
errOAAI
errEfstathiou, E.; Tsikkinis, A.; Wen, S.; Tapia, E. Li Ning; Hoang, A.; Aparicio, A.; Tu, S-M.; Rangel, G.; Troncoso, P.; Corn, P.; Araujo, J.; Logothetis, C.
errShare
errSave
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
err2016-01-25
err77
errOAAI
errParanjape, A. N.; Soundararajan, R.; Werden, S. J.; Joseph, R.; Taube, J. H.; Liu, H.; Rodriguez-Canales, J.; Sphyris, N.; Wistuba, I.; Miura, N.; Dhillon, J.; Mahajan, N.; Mahajan, K.; Chang, J. T.; Ittmann, M.; Maity, S. N.; Logothetis, C.; Tang, D. G.; Mani, S. A.
errShare
errSave
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial
err2012-03-01
err37
errOAAI
errZurita, A. J.; George, D. J.; Shore, N. D.; Liu, G.; Wilding, G.; Hutson, T. E.; Kozloff, M.; Mathew, P.; Harmon, C. S.; Wang, S. L.; Chen, I.; Maneval, E. Chow; Logothetis, C. J.
errShare
errSave
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
err2012-01-01
err102
errOAAI
errZurita, A. J.; Jonasch, E.; Wang, X.; Khajavi, M.; Yan, S.; Du, D. Z.; Xu, L.; Herynk, M. H.; Mckee, K. S.; Tran, H. T.; Logothetis, C. J.; Tannir, N. M.; Heymach, J. V.
errShare
errSave
Final Overall Survival (OS) Analysis of COU-AA-301, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pretreated With Docetaxel
err2011-09-01
err5
PREAI
errFizazi, K.; Scher, H. I.; Molina, A.; Logothetis, C. J.; Jones, R. J.; Staffurth, J. N.; Li, J.; Kheoh, T.; Haqq, C. M.; de Bono, J. S.
errShare
errSave
A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation
err2008-05-19
err30
errOAAI
errLin, S-H; Cheng, C-J; Lee, Y-C; Ye, X.; Tsai, W-W; Kim, J.; Pasqualini, R.; Arap, W.; Navone, N. M.; Tu, S-M; Hu, M.; Yu-Lee, L-Y; Logothetis, C. J.
errShare
errSave
Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone
err2007-08-13
err63
errOAAI
errLi, Z. G.; Yang, J.; Vazquez, E. S.; Rose, D.; Vakar-Lopez, F.; Mathew, P.; Lopez, A.; Logothetis, C. J.; Lin, S-H; Navone, N. M.
errShare
errSave
15-lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor γ
err2006-05-08
err27
PREAI
errSubbarayan, V.; Krieg, P.; Hsi, L. C.; Kim, J.; Yang, P.; Sabichi, A. L.; Llansa, N.; Mendoza, G.; Logothetis, C. J.; Newman, R. A.; Lippman, S. M.; Menter, D. G.
errShare
errSave
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
err2002-05-20
err28
errOAAI
errFizazi, K; Prow, DM; Do, KA; Wang, X; Finn, L; Kim, J; Daliani, D; Papandreou, CN; Tu, SM; Millikan, RE; Pagliaro, LC; Logothetis, CJ; Amato, RJ
errShare
errSave
Germ-cell tumor survivors: the price for cure
err2002-02-01
err10
PREAI
errFizazi, K; Chen, I; Logothetis, CJ
errShare
errSave
errShare
errSave
Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells
err2001-01-15
err23
PREAI
errSchumacher, G; Bruckheimer, EM; Beham, AW; Honda, T; Brisbay, S; Roth, JA; Logothetis, C; McDonnell, TJ
errShare
errSave
Workgroup 3 - Current prognostic factors and their relevance to staging
errCANCER
IF5.1
err1996-07-15
err14
PREAI
errHutter, RVP; Montie, JE; Busch, C; Grignon, DJ; Lieber, M; Logothetis, C; Ragde, H; Reuter, VE
errShare
errSave